FDA cancels recall of superbug-linked scope cleaners

Hospitals still must not use the reprocessors in question to disinfect some endoscopes


The Food and Drug Administration (FDA) has canceled the recall of superbug-linked scope cleaners, according to an article on the Fierce Healthcare website. 

The FDA said that while hospitals can't use Custom Ultrasonics' System 83 Plus Automated Endoscope Reprocessors (AERs) to disinfect the duodenoscopes linked to superbug outbreaks, they could be used for other endoscopes.

Custom Ultrasonics is working with the FDA to resolve duodenoscope issues as quickly as possible, the company said.

The results of a Senate investigation published in January faulted regulators, hospitals and scope manufacturers along with Custom Ultrasonics for outbreaks.

Read the article.

 

 



May 17, 2016


Topic Area: Industry News


Recent Posts

Barriers to Infection: Rethinking Mattress Cleaning

Laundering removable bed barriers provides a more effective, consistent and safer method for eliminating harmful bacteria compared to manual cleaning.


Over 1 Million Individuals Affected in Community Health Center Data Breach

No evidence of data misuse has been found so far.


Prospect Medical Holdings to Sell Crozer Health to Non-Profit Consortium

The sale includes Crozer Health’s operating assets, including all hospitals, ambulatory surgery centers, clinics and physician offices.


The Top States for Pest Infestations

Healthcare facilities are among the most popular locations for pest infestations.


Ground Broken on Wichita Biomedical Campus Project

The $172.5-million, eight-story, 350,000-square-foot building is expected to open in 2027.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.